Last updated 2026-07-26
- Acquired Immunorizon for $100M, Feb 2023
- Acquired FameWave, Jan 2020
- Acquired TyrNovo, Oct 2017
Total raised
$141.3M
Last: Public Offering 2024-12
Stage
Public
Founded
1968
Headcount
10
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Purple Biotech Ltd. is an Israeli clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. The company is committed to developing first-in-class, effective therapies that harness the power of the tumor microenvironment to overcome drug resistance and improve treatment outcomes for cancer patients. Its oncology pipeline includes a preclinical tri-specific antibodies platform, CAPTN-3 (with therapeutic candidates IM1240 and IM1305), and two other oncology therapeutic candidates in clinical trial phases, CM24 and NT219. Purple Biotech was formerly known as Kitov Pharma Ltd. and changed its name in December 2020.
Funding history · 15 rounds · $141.3M total
15 events/rounds · $141.3M Total Funding: $141.3M in Public Equity
Sep 2025
Jan 2025
Jul 2024
Nov 2023
Apr 2023
Mar 2022
Jun 2021
Jun 2020
Oct 2019
Jan 2019
Jun 2018
Jan 2018
Jul 2017
Jul 2016
Dec 2015
Acquisitions · 3
Headcount over time
10 employees (2026-09) · 1 point
Offices
Rehovot, Israel · HQ / main office
Q&A
- What is Purple Biotech's primary focus?
- Purple Biotech is a clinical-stage biotechnology company dedicated to developing first-in-class therapies to overcome tumor immune evasion and drug resistance for cancer patients.
- When was Purple Biotech founded and where is it headquartered?
- Purple Biotech was founded in August 1968 and is headquartered in Rehovot, Israel.
- What was Purple Biotech formerly known as?
- Purple Biotech was formerly known as Kitov Pharma Ltd. and changed its name in December 2020.
- What is the most recent funding round for Purple Biotech?
- Purple Biotech completed a Public Offering in December 2024, raising $2.8 million.
- What is Purple Biotech's total funding raised to date?
- Purple Biotech has raised a total of $84.34 million across all funding rounds.
- How many employees does Purple Biotech currently have?
- Purple Biotech has 1-10 employees.
- What is the most recent acquisition made by Purple Biotech?
- In February 2023, Purple Biotech acquired Immunorizon for $100 million.
- Who is the CEO of Purple Biotech?
- Gil Efron serves as the Chief Executive Officer of Purple Biotech.
Team · 14
Gil Efron
Chief Executive Officer
Hadas Reuveni
Vice President Research & Development
Michael Schickler
Head of Clinical and Regulatory Affairs
Shai Lankry
Chief Financial Officer
Eric Rowinsky
Chairman of the Board
Isaac Israel
Director
Simcha Rock
Director
Ido Agmon
Director
Robert Gagnon
Director
Suzana Nahum-Zilberberg
Director
Yael Margolin
Director
Eyal Gottlieb
Scientific Advisory Board
Steven Maron
Scientific Advisory Board
Sunil Sharma
Scientific Advisory Board
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Highlights
Patents
Tags
immunotherapyantibodiespharmaceuticalsoncologycancercancer-therapydrug-developmentbiotechnologylife-sciences
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | purple-biotech.com/ |
|---|---|
| linkedin.com/company/6758085 |
Identifiers & details
| Legal name | Purple Biotech Ltd. |
|---|---|
| Founded | 1968-8 |
| Employees (exact) | 10 |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Immunorizon | 2023-02 | $100.0M |
| FameWave | 2020-01 | |
| TyrNovo | 2017-10 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | purple-biotech.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 520031238 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 1968-08-12 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 1996 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | דרך בגין 132 תל אביב - יפו |